703 related articles for article (PubMed ID: 32798146)
21. Impact of Neoadjuvant Chemotherapy on Pathologic Response in Patients With Upper Tract Urothelial Carcinoma Undergoing Extirpative Surgery.
Almassi N; Gao T; Lee B; Stein RJ; Haber GP; Ornstein MC; Rini BI; Gilligan TD; Garcia JA; Stephenson AJ; Grivas P
Clin Genitourin Cancer; 2018 Dec; 16(6):e1237-e1242. PubMed ID: 30217764
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
[TBL] [Abstract][Full Text] [Related]
23. Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
Hosogoe S; Hatakeyama S; Kusaka A; Hamano I; Iwamura H; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ohyama C
Eur Urol Focus; 2018 Dec; 4(6):946-953. PubMed ID: 28753881
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis.
Wu Z; Li M; Wang L; Paul A; Raman JD; Necchi A; Psutka SP; Buonerba C; Zargar H; Black PC; Derweesh IH; Mir MC; Uzzo RG; Pandolfo SD; Autorino R; DI Lorenzo G
Minerva Urol Nephrol; 2022 Oct; 74(5):518-527. PubMed ID: 35383431
[TBL] [Abstract][Full Text] [Related]
25. Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy.
Fletcher SA; Pallauf M; Watts EK; Lombardo KA; Campbell JA; Rezaee ME; Rouprêt M; Boorjian SA; Potretzke AM; Roshandel MR; Ploussard G; Djaladat H; Ghoreifi A; Mari A; Campi R; Khene ZE; Raman JD; Kikuchi E; Rink M; Abdollah F; Boormans JL; Fujita K; D'Andrea D; Soria F; Breda A; Hoffman-Censits J; McConkey DJ; Shariat SF; Pradere B; Singla N
Eur Urol Oncol; 2024 Jan; ():. PubMed ID: 38262800
[TBL] [Abstract][Full Text] [Related]
26. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma.
Labbate CV; Hensley PJ; Miest TS; Qiao W; Adibi M; Shah AY; Chery L; Papadopoulos J; Siefker-Radtke AO; Gao J; Guo CC; Czerniak BA; Navai N; Kamat AM; Dinney CP; Campbell MT; Matin SF
Urol Oncol; 2022 Oct; 40(10):454.e17-454.e23. PubMed ID: 35961847
[TBL] [Abstract][Full Text] [Related]
28. Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma.
Zennami K; Sumitomo M; Takahara K; Nukaya T; Takenaka M; Fukaya K; Ichino M; Fukami N; Sasaki H; Kusaka M; Shiroki R
BJU Int; 2021 Mar; 127(3):332-339. PubMed ID: 32896105
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant Radiotherapy for Upper Tract Urothelial Carcinoma: Systematic Review and Meta-Analysis.
Zalay O; Yan M; Sigurdson S; Malone S; Vera-Badillo FE; Mahmud A
Curr Oncol; 2022 Dec; 30(1):19-36. PubMed ID: 36661651
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant Chemotherapy Benefits Survival in High-Grade Upper Tract Urothelial Carcinoma: A Propensity Score-Based Analysis.
Chen L; Ou Z; Wang R; Zhang M; He W; Zhang J; Zu X; Yi L; Xu R; Jiang S; Qi L; Wang L
Ann Surg Oncol; 2020 Apr; 27(4):1297-1303. PubMed ID: 31853757
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemotherapy for upper tract urothelial carcinoma.
Kim DK; Cho KS
Transl Cancer Res; 2020 Oct; 9(10):6576-6582. PubMed ID: 35117267
[TBL] [Abstract][Full Text] [Related]
32. Overview, Diagnosis, and Perioperative Systemic Therapy of Upper Tract Urothelial Carcinoma.
Kolawa A; D'Souza A; Tulpule V
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835507
[TBL] [Abstract][Full Text] [Related]
33. Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study.
Song W; Jeong JY; Jeon HG; Seo SI; Jeon SS; Choi HY; Lee HM; Sung HH
Int J Surg; 2019 Jun; 66():12-17. PubMed ID: 31018160
[TBL] [Abstract][Full Text] [Related]
34. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M
Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042
[TBL] [Abstract][Full Text] [Related]
35. Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma.
Pradere B; D'Andrea D; Schuettfort VM; Foerster B; Quhal F; Mori K; Abufaraj M; Margulis V; Deuker M; Briganti A; Muilwijk T; Hendricksen K; Lotan Y; Karakiewic P; F Shariat S;
World J Urol; 2021 Jul; 39(7):2567-2577. PubMed ID: 33067726
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration.
Necchi A; Lo Vullo S; Mariani L; Moschini M; Hendricksen K; Rink M; Sosnowski R; Dobruch J; Raman JD; Wood CG; Margulis V; Roupret M; Briganti A; Montorsi F; Xylinas E; Shariat SF;
BJU Int; 2018 Feb; 121(2):252-259. PubMed ID: 28940605
[TBL] [Abstract][Full Text] [Related]
37. Design and rationale of a single-arm phase II study of neoadjuvant Durvalumab and Gemcitabine associated with Cisplatin or Carboplatin for upper urinary tract urothelial cancer: the iNDUCT trial (NCT04617756).
Calleris G; Rouprêt M; Seisen T; Bendjeddou L; Chevallier T; Masson-Lecomte A; Thibault C; Neuzillet Y; Audenet F; Xylinas E; Houédé N
World J Urol; 2023 Dec; 41(12):3413-3420. PubMed ID: 37698632
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
Porten S; Siefker-Radtke AO; Xiao L; Margulis V; Kamat AM; Wood CG; Jonasch E; Dinney CP; Matin SF
Cancer; 2014 Jun; 120(12):1794-9. PubMed ID: 24633966
[TBL] [Abstract][Full Text] [Related]
39. [Prospective controlled observation ofeffect of adjuvant chemotherapy onsurvival and prognosis ofhigh-risk upper tract urothelial carcinoma patients underwent radical nephroureterectomy].
Luo Y; Feng BF; Wei DC; Han YL; Li MC; Zhao JH; Lin YH; Li Q; Hou Z; Zhang GY; Jiang YG
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3158-3163. PubMed ID: 31694107
[No Abstract] [Full Text] [Related]
40. Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.
Adibi M; McCormick B; Economides MP; Petros F; Xiao L; Guo C; Shah A; Kamat AM; Dinney C; Navai N; Gao J; Siefker-Radtke A; Matin SF; Campbell MT
Clin Genitourin Cancer; 2022 Apr; 20(2):176-182. PubMed ID: 35039231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
